Healthcare resource utilization and patient-reported outcomes (PROs) for intradural extramedullary (IDEM) spine tumors are not well reported. OBJECTIVE: To analyze the PROs, costs, and resource utilization 1 year following surgical resection of IDEM tumors. METHODS: Patients undergoing elective spine surgery for IDEM tumors and enrolled in a single-center, prospective, longitudinal registry were analyzed. Baseline and postoperative 1-year PROs were recorded. One-year spine-related direct and indirect healthcare resource utilization was assessed. One-year resource use was multiplied by unit costs based on Medicare national payment amounts (direct cost). Patient and caregiver workday losses were multiplied by the self-reported gross-of-tax wage rate (indirect cost). RESULTS: A total of 38 IDEM tumor patients were included in this analysis. There was significant improvement in quality of life (EuroQol-5D), disability (Oswestry and Neck Disability Indices), pain (Numeric rating scale pain scores for back/neck pain and leg/arm pain), and general physical and mental health (Short-form-12 health survey, physical and mental component scores) in both groups 1 year after surgery (P < .0001). Eighty-seven percent (n = 33) of patients were satisfied with surgery. The 1-year postdischarge resource utilization including healthcare visits, medication, and diagnostic cost was $4111 ± $3596. The mean total direct cost was $23 717 ± $7412 and indirect cost was $5544 ± $4336, resulting in total 1-year cost $29 177 ± $9314. CONCLUSION: Surgical resection of the IDEM provides improvement in patient-reported quality of life, disability, pain, general health, and satisfaction at 1 year following surgery. Furthermore, we report the granular costs of surgical resection and healthcare resource utilization in this population.
I
ntradural spinal tumors have an incidence of approximately 2 to 4 per 100 000 people. [1] [2] [3] [4] Intradural tumors can be classified as intradural extramedullary (IDEM) or intramedullary. Common IDEM lesions include schwannomas, meningiomas, and neurofi-ABBREVIATIONS: CSF, cerebrospinal fluid; EQ-5D, EuroQol-5D; IDEM, intradural extramedullary; MCS, mental component score; NRS, Numeric rating scale; ODI, Oswestry Disability Index; PCS, physical component score; PRO, patient-reported outcome; SF-12, Short-form -12 bromas. 2, 5, 6 IDEM tumors present with pain and/or neurological deficit and are often benign but have potential for local recurrence, highlighting the importance of a meticulous surgical resection. [7] [8] [9] [10] The goal of surgery is complete resection with decompression of adjacent neural structures via the least invasive approach possible. Several studies exist assessing efficacy, surgical approach, and complications associated with surgery for IDEM tumors. 5, [11] [12] [13] [14] [15] The estimated healthcare burden of treating patients with spinal disorders ranges from $80 to $100 billion. [16] [17] [18] [19] [20] Given the unsustainable cost of the current US healthcare system, value-based purchasing is being rapidly implemented. 21 Therefore, it is vital to determine accurate measurement of the clinical benefit and resource utilization in defining value-based care for spine disorders. Prospective registries have emerged as a feasible avenue to capture the real-world effectiveness via patientreported outcomes (PROs), incorporating patients' general health status, quality of life, disease-specific health, healthcare resource utilization, societal productivity, and satisfaction with care. The data on PROs, resource utilization, and cost following surgery for spine tumors are sparse. 1, [22] [23] [24] The majority of resource utilization studies in spinal oncology are restricted to metastatic populations. [25] [26] [27] In this analysis, we set out to report 1-year PROs, resource utilization, and cost associated with surgical resection of IDEM tumors.
METHODS
Patients undergoing elective surgery for IDEM spine tumor at a single comprehensive spine center over a period of 5 years (October 2010 to present) were enrolled into a prospective, web-based longitudinal registry. An approval for the study and wavier of informed consent was obtained from the institutional review board for all the patients entered into the registry. The inclusion criteria for the study were (1) patients with age >18 years; (2) imaging findings of IDEM spinal tumor; (3) intraoperatively and pathologically confirmed IDEM tumors; and (4) patients for whom complete preoperative variables and follow-up data were available at the time of analysis. The exclusion criteria were (1) intraoperative and pathological diagnosis of non-IDEM tumor pathology; (2) any extraspinal cause of back or leg pain; (3) an active medical or workman's compensation lawsuit; and (4) patients that were unwilling or were unable to participate in the follow-up questionnaires.
Patients received standard preoperative antibiotics and mechanical deep venous thrombosis prophylaxis. Standard open resection of all the IDEM tumors was performed. All tumor specimens were reviewed by a neuropathologist and recorded in the operative note.
Outcome Measures
Patient demographics, comorbidities, clinical presentation, operative variables, and postoperative morbidity were assessed. PROs for disability, pain, quality of life, and satisfaction were recorded at baseline, 3 months, and 1 year after surgery. The outcomes were assessed via phone interview conducted by an independent data coordinator not involved with clinical care. PRO instruments included (1) quality of life-EuroQol-5D (EQ-5D) 28 ; (2) back/neck-related disability: Oswestry Disability Index (ODI) or Neck Disability Index 29 ; (3) Numeric rating scale (NRS) pain scores for back/neck pain and leg/arm pain 30 ; and (4) general health: Short-form-12 health survey (SF-12), physical component score (PCS), and mental component score (MCS). 31 Patient satisfaction was captured using North American Spine Society 4-point satisfaction questionnaire.
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Cost
Total costs were derived as the sum of hospital costs, surgeons' professional fees, and postdischarge resource utilization. The costs were recorded based on resource utilization, derived from both patientreported use and institutional records. All billable procedures from the index hospitalization and all billable medical resource utilization were recorded prospectively. The hospital cost was based on the procedure performed, the severity of the individual case, and whether complications occurred, which collectively determined the diagnosis-related group. Surgeons' professional fees were derived based on current procedural terminology codes. All costs were estimated based on Medicare national payment amounts, because the negotiated private payer cost can be interpreted as percentages of Medicare cost. A unit multiplier was used to standardize and eliminate any geographic variations. Ancillary postdischarge resource utilization was derived from current procedural terminology codes assigned for patient self-reported resource utilization. Low back-related outpatient visits to surgeons, other physicians, chiropractors, physical and occupational therapists, and acupuncturists were captured. Diagnostic tests including radiographs, computerized tomography (CT) scans, magnetic resonance (MR) imaging, and electromyography were tracked. Pre-and postoperative devices utilized (canes and walkers), epidural steroid injections, emergency department visits, back-specific medications (nonsteroidal anti-inflammatory drugs, oral steroids, narcotics, muscle relaxants, and antidepressants), and inpatient or outpatient rehabilitation days were assessed. The costs associated with readmissions to our institution during the 90-day global period were also recorded. Indirect costs included patient or family member workday losses and cost of a caregiver, if this was needed. Lost workdays were estimated by assessing the productivity losses due to spine-related problems such as missed workdays for those employed outside the home. Costs for missed days were estimated based on average gross wages plus nonhealth benefits. Such calculations have been reported previously.
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Statistical Analysis
Mean (standard deviation) and median (range) for continuous variables and frequency for categorical variables were computed. Paired Student's t-test was used to compare the baseline and postoperative 1-year PROs. A P-value ≤ .05 was considered statistically significant. Analysis was performed using SPSS version 20 (IBM Inc., Amronk, New York).
RESULTS
Of total, 57 patients undergoing surgery for IDEM tumor resection, 38 patients with completed 1-year follow-up cost data and PROs were analyzed further. Table 1 summarizes the characteristics of the study cohort. Schwannoma (39%) was the most common tumor type followed by meningioma (26%). Twenty-four percent of tumors (n = 9) were cervical, and 76% (n = 29) were thoracolumbar, of which n = 9 were thoracic spine and n = 20 were located in lumbar spine. All tumors in this study were resected via an open, posterior approach. In total, 37% (n = 14) of patients underwent laminectomy with fusion. Fusion was reserved when tumor removal required a facetectomy or transpedicular approach, thus destabilizing the involved segments. The mean number of levels operated on was 2.2 ± 1.2 levels. The mean hospital stay was 4.7 ± 3.7 days. Table 2 summarizes the baseline, postoperative 1-year PROs and change scores for PROs at 1-year, satisfaction, 90-day complication and readmission after surgery. There was significant improvement in the quality of life (EQ-5D: 0.62 ± 0.21 vs 0.77 ± 0.20, P < .0001), disability (ODI/NDI: 39 ± 21 vs 24 ± 20, P < .0001), pain (NRS-back/neck pain: 5.1 ± 3.3 vs 3.1 ± 3.1, P = .001, NRS-leg/arm pain: 4.7 ± 3.9 vs 2.7 ± 3.1, P = .016), general physical (SF-12 PCS: 31.1 ± 13.1 vs 39.7 ± 13.6, P < .0001) and mental (SF-12 MCS: 48.5 ± 13.7 vs 52.7 ± 12.1, P = .05) health scores ( Figure) . In total, 87% (n = 33) achieved satisfaction with outcome 1 year after surgery. Of this, 66% of patients (n = 25) achieved the highest level of satisfaction (surgery met their expectations). There were total 6 complications (15.7%) in 5 patients including urinary tract infection (n = 4, 11%) and new neurological deficits (n = 2, 5%). One patient (3%) was readmitted for breakthrough seizures within postoperative 90 days. Table 3 summarizes the 1-year postdischarge resource utilization following surgery for IDEM spine tumors. The 1-year postdischarge resource utilization was $4111 ± $3596. Fifty-five percent (n = 21) of patients were employed preoperatively. Seventy-one percent of patients (n = 15) returned to work at 3 month following surgery. The median patient days lost was 25 days and the average income loss in those employed preoperatively was $6187 ± $4300. The family member had to take time off work for a median of 8 days, in 34% (n = 13) of patients. The mean family income loss for those patients was $2467 ± $3305. Two patients hired a caregiver for average 25 days, resulting in mean caregiver cost of $4407. Table 4 summarizes the direct and indirect costs for surgical resection for IDEM tumor patients. The mean direct cost of 1 year was $23 717 ± $7412 and indirect cost was $5544 ± $4336, resulting in total 1-year cost $29 177 ± $9314.
Outcomes
Costs and Healthcare Resource Utilization
FIGURE. Demonstration of improvement in 1-year quality of life (EQ-5D), disability ODI/NDI, NRS-back/neck pain, leg/arm pain, and general physical health scores (SF-12 PCS) and mental health score (SF-12 MCS) among IDEM tumor patients.
DISCUSSION
In the era of increasingly scarce healthcare resources and escalating costs, it is imperative to understand the resource utilization associated with various spinal pathologies. The resource utilization and costs following resection of the IDEM tumors have not been previously described. In this analysis, utilizing prospectively collected data, we report the PROs, direct and indirect costs, and resource utilization at 1 year following elective spine surgery in IDEM tumor patients.
Previous studies have addressed PROs for IDEM tumor patients, 2, 22 with only 1 assessing the efficacy of surgery. 2 Bellut et al 2 recently demonstrated that the Core Outcomes Measures Index, a PRO instrument for patients with spine disorders, was able to recognize reduction in axial pain, peripheral pain, and back-related function at 3 months postoperatively (P < .001), with no further reduction at 1 year (P > .05), and the modified McCormick scale recognized improvement at 1 year (P < .004) after surgery. In the only other study evaluating PROs in patients undergoing surgery for primary intradural CPT, current procedural terminology codes; DRG, diagnosis-related group. a The mean patient income loss is computed for those preoperatively employed; mean family income loss is computed for those patients whose family took time off work to care for patient; and mean caregiver cost is computed for those who hired caregiver.
spine tumors, Guirado et al 22 demonstrated the validity of the SF-36 in intradural spine tumor patients by comparing the SF-36 to results from the McCormick and Aminoff-Logue scales in a cohort of 100 intradural spine tumor patients. 22 No postoperative PROs were reported to assess outcomes after surgery.
In the present analysis, we found that there was a significant improvement in PROs 1 year following surgery for IDEM tumor patients. The resection of IDEM spine tumors requires a meticulous dural closure to reduce the risk of cerebrospinal fluid (CSF) leaks. The reported rate of CSF leak following spine tumors has been reported to range from 0% to 9%. 5, [38] [39] [40] In our study, no patients had CSF leaks and 3 patients (8%) had major complications. Two patients developed new neurological deficits and 1 had breakthrough seizure, in the setting of a known seizure disorder. This suggests that the patients undergoing surgical resection of IDEM tumors gain significant postoperative benefits, in terms of PROs with few complications.
Few studies have discussed healthcare utilization associated with intradural spinal tumors 14, 15, 24, 41 as compared to multiple studies assessing costs in the treatment of metastatic epidural spinal cord compression. [25] [26] [27] 42, 43 Sharma et al 14 reported that the mean total hospital charges for treating intramedullary spine tumors in the National Inpatient Sample from 2003 to 2010 was $61 157. However, this is an administrative database with its inherent inaccuracies. A recent study reported that the lifetime cost of treating spinal metastasis was within the range €36 616 and €87 819 based on the type of primary treatment received. 44 Also in a metastatic cohort, a recent UK study found that better health status predicted higher costs, concluding that healthier patients had capacity for larger operations. 27 Direct costs per patient averaged €16 885. 27 Consistent with our results, Fontes et al reported $21 307-hospital cost for surgical treatment of IDEM spine tumors. 45 We found that the direct cost for surgical treatment of IDEM spine tumors was $23 717 at 1 year following surgery. As the IDEM patients are followed over time with neurological examination and serial magnetic resonance imaging (MRI) to monitor for recurrence, the imaging utilization will likely be higher for reasons of surveillance. 13, 38, 46, 47 Furthermore, steroids are often indicated to ameliorate the peritumoral vasogenic edema, resulting in increased medication cost and overall resource utilization.
In this study, we provide a comprehensive assessment of direct and indirect cost estimates of surgery for IDEM spine tumors. When interpreting the economic value of a treatment, it is important to consider from whose perspective the costs are reported. From the payer and hospital's perspective, the direct costs, which represent the expenditure of the hospital to deliver care, are concerned. Several socioeconomic studies have preferred societal perspective (indirect cost) to report cost and value of spine care. 48, 49 Both direct costs (hospital costs and other healthcare resource utilization) and indirect costs (productivity losses of patient, family, and caregivers) are vital component of costs reported from societal perspective. 50 The indirect cost associated with spine tumors has not been reported previously. Importantly, our analysis of missed work productivity demonstrated an indirect mean societal cost of $13 061 for those that were employed preoperatively or incurred the productivity lost due to family member missed days and costs associated with caregiver. We demonstrate the value of surgical resection of IDEM spine tumors from payers, providers, hospital, and societal perspective.
Limitations
There are several limitations to this study. The number of patients in the IDEM group was relatively smaller and about onethird of the patients were lost to follow-up; however, given the rarity of these tumors, the number is comparable to the previously reported studies. The cost estimates and resource utilization in our study are evaluated based on the patient-reported resource utilization and chart biopsy. For the postoperative care that was sought outside our hospital was not recorded and hence not included in the analysis if the patient did not report it at the time of interview. 33 Furthermore, we report a single-center cost data; the direct costs are reported from Medicare perspective, which may vary based on the regional variation in Medicare reimbursement and might be different for commercial payers Therefore, the cost analysis using multicenter spine registries is imperative to provide accurate national cost estimates for various spine surgery. We report the first well-designed prospective study that analyzed the cost, resource utilization, and PROs for IDEM spine tumor population. The outcome measure more commonly used in the spine tumor literature was not included in this study, as the focus of our analysis was to report patient-reported resource utilization and PROs commonly used for other spine pathologies. Clearly, further studies with large number of IDEM tumor patients with comprehensive outcomes and cost analysis are needed to accurately evaluate the economic burden associated with IDEM spine tumors.
CONCLUSION
Surgical resection of the IDEM provides improvement in patient-reported quality of life, disability, pain, general health, and satisfaction at 1 year following surgery. Furthermore, we report the granular costs of surgical resection and healthcare resource utilization in this population.
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